The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
October 2nd 2024
In May 2024, the first biosimilars for aflibercept were approved, which included aflibercept-jbvf (Yesafili; Biocon Biologics), known as MYL-1701P.
The Mechanism of Action of Inclisiran for LDL-C Management in ASCVD
January 21st 2022Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discussed inclisiran’s mechanism of action and how it supports LDL-C management for patients with ASCVD.
Watch
The Impact of the Pandemic on the Advancement of Data Interoperability, Drug Development
January 20th 2022Shreejit Nair, senior vice president and life sciences market business lead at CitiusTech, discussed what the impact of the pandemic has been on the advancement of data interoperability in health care.
Watch
How Inclisiran Helps to Manage LDL-C for Patients With ASCVD
January 20th 2022Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran, discussed the trial results assessing the efficacy and safety of inclisiran for patients with atherosclerotic cardiovascular disease.
Watch
White House to Ship 400 Million N95 Masks to Retail Pharmacies, Health Centers This Week
January 19th 2022The Biden administration announced that it would make 400 million nonsurgical N95 masks for US citizens available free of charge at community health centers and retail pharmacies across the United States.
Read More